Skip to main content
Clinical Trials/NCT06012799
NCT06012799
Recruiting
Not Applicable

Prospective Observational Study for Efficacy of Perioperative Serum Glucose Level Evaluated by Continuous Glucose Monitoring System in Kidney Transplantation Patients

Seoul National University Hospital1 site in 1 country100 target enrollmentMay 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
New Onset Diabetes After Transplantation
Sponsor
Seoul National University Hospital
Enrollment
100
Locations
1
Primary Endpoint
Rate of NODAT
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

his study aims to utilize Continuous Glucose Monitoring (CGM) to observe glucose fluctuations in kidney transplant recipients and predict New-Onset Diabetes After Transplantation (NODAT) based on these patterns. Additionally, it seeks to investigate glucose variability resulting from medications and surgeries such as immunosuppressants and steroid regimens post-kidney transplantation. This prospective observational study anticipates identifying factors influencing blood glucose levels and contributing to future research on blood glucose management using CGM monitoring in kidney transplant patients.

Registry
clinicaltrials.gov
Start Date
May 15, 2021
End Date
December 30, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The study will target 100 kidney transplant patients who have provided consent, among those who underwent the procedure at Seoul National University Hospital after March 2021.

Exclusion Criteria

  • multi-organ transplant
  • history of previous kidney transplant
  • less than 18 years old

Outcomes

Primary Outcomes

Rate of NODAT

Time Frame: 6 months after kidney transplantation

rate of new onset diabetes after transplantation

Study Sites (1)

Loading locations...

Similar Trials